NCT06786650

Comparision of the Analgesic Effects of Intravenous Ibuprofen and Tenoxicam in Acute Migraine Attack

• Status: Active Not Recruiting
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 100 (estimated)
• Sponsor: Haydarpasa Numune Training and Research Hospital · Academic / Other
• Sex: All
• Age: 18 Years – 65 Years
• Healthy volunteers: Not accepted

Summary

The aim of this clinical trial is to compare the efficacy of two different non-steroidal anti-inflammatory analgesic drugs in the palliation of headache in acute migraine attack. The main questions it aims to answer are: 1. Is there a difference between the efficacy of two different nonsteroidal anti-inflammatory analgesics? 2. Is there a significant difference between the side effects of two different nonsteroidal anti-inflammatory drugs? Researchers will compare intravenous tenoxicam to intravenous ibuprofen to see if tenoxicam works to treat migraine attack. Treatments will; 1. be administered in 100 cc saline to ensure blinding in the group. 2. Randomisation will be done by closed envelope method. 3. Numerical Pain Scale (NRS) will be used to evaluate the analgesic efficacy of the drugs. NRS scores will be recorded in both groups before starting treatment (baseline) and at 30, 60 and 120 minutes after treatment. 4. Any side effects due to medication will be recorded.

Conditions

• Migraine
• Analgesic Affect
• Emergency Medicine

Interventions

Type	Name	Description
DRUG	Tenoxicam Injectable Product	Analgesic efficacy of the two active agents analysed in our study in acute migraine attack has not been compared before.
DRUG	ibuprofen	Analgesic efficacy of the two active agents analysed in our study in acute migraine attack has not been compared before.

Timeline

• Start date: 2024-05-15
• Primary completion: 2024-10-15
• Completion: 2025-06-30
• First posted: 2025-01-22
• Last updated: 2025-06-26

Locations

1 site across 1 country: Turkey (Türkiye)